Overview

  • Product name(-)-Cytisine
  • Description
    Potent, selective nAChR agonist
  • Biological descriptionPotent, selective agonist at neuronal nicotinic receptors. Acts as a partial agonist at β2-containing nicotinic receptors. (Ki values are 2 (α4β2), 5890 (α7), 480 (α3β4), 329 (α6/α4β4) and 492 nM (α1β1γδ)).
  • Purity> 99%

Properties

    References for (-)-Cytisine (ab120537)

    This product has been referenced in:
    • Rollema H  et al. Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. Br J Pharmacol 160:334-45 (2010). Read more (PubMed: 20331614) »
    • LeSage MG  et al. Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats. Pharmacol Biochem Behav 91:461-7 (2009). Read more (PubMed: 18817808) »
    • Papke RL & Heinemann SF Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit. Mol Pharmacol 45:142-9 (1994). Read more (PubMed: 8302273) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120537.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"